HK1095133A1 - Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them - Google Patents
Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing themInfo
- Publication number
- HK1095133A1 HK1095133A1 HK07102213.0A HK07102213A HK1095133A1 HK 1095133 A1 HK1095133 A1 HK 1095133A1 HK 07102213 A HK07102213 A HK 07102213A HK 1095133 A1 HK1095133 A1 HK 1095133A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tricyclic derivatives
- preparations
- pharmaceutically acceptable
- pharmaceutical compositions
- acceptable salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/22—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of rings other than six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
- C07C2603/34—Benzoheptalenes; Hydrogenated benzoheptalenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20030041547 | 2003-06-25 | ||
PCT/KR2004/001518 WO2004113281A1 (en) | 2003-06-25 | 2004-06-23 | Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1095133A1 true HK1095133A1 (en) | 2007-04-27 |
Family
ID=36091400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK07102213.0A HK1095133A1 (en) | 2003-06-25 | 2007-02-27 | Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them |
Country Status (14)
Country | Link |
---|---|
US (1) | US20070179143A1 (xx) |
EP (1) | EP1646608B1 (xx) |
JP (1) | JP4430071B2 (xx) |
KR (1) | KR100667464B1 (xx) |
CN (1) | CN100393698C (xx) |
AT (1) | ATE500216T1 (xx) |
AU (1) | AU2004249639B2 (xx) |
CA (1) | CA2531543C (xx) |
DE (1) | DE602004031621D1 (xx) |
DK (1) | DK1646608T3 (xx) |
ES (1) | ES2358801T3 (xx) |
HK (1) | HK1095133A1 (xx) |
RU (1) | RU2326864C2 (xx) |
WO (1) | WO2004113281A1 (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7622612B2 (en) | 2001-05-28 | 2009-11-24 | Chemtech Research Incorporation | Tricyclic derivatives and their use |
US7507842B2 (en) | 2005-08-12 | 2009-03-24 | Radiorx, Inc. | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof |
US20070135380A1 (en) | 2005-08-12 | 2007-06-14 | Radiorx, Inc. | O-nitro compounds, pharmaceutical compositions thereof and uses thereof |
SI2562170T1 (sl) | 2006-02-21 | 2015-03-31 | Toyama Chemical Co., Ltd. | Postopek za izdelavo 3-(5-(4-(ciklopentiloksi)-2-hidroksibenzoil)-2-((3-okso-2-substituiran- 2,3-dihidro-1,2-benzizoksazol-6-il)metoksi)fenil)propionat estra in intermediata za ta postopek |
KR101077609B1 (ko) | 2009-07-08 | 2011-10-27 | 제일약품주식회사 | 트리사이클릭 유도체의 제조방법 |
EP2470499B1 (en) * | 2009-08-26 | 2019-06-12 | Alberta Health Services | Novel colchicine derivatives, methods and uses thereof |
US8471041B2 (en) | 2010-02-09 | 2013-06-25 | Alliant Techsystems Inc. | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same |
KR101130754B1 (ko) * | 2010-06-25 | 2012-03-28 | 제일약품주식회사 | 난용성 트리사이클릭 유도체 화합물의 용해도가 향상된 약학적 조성물 |
US8664247B2 (en) | 2011-08-26 | 2014-03-04 | Radiorx, Inc. | Acyclic organonitro compounds for use in treating cancer |
US20140308260A1 (en) | 2011-10-07 | 2014-10-16 | Radiorx, Inc. | Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products |
WO2013052164A1 (en) | 2011-10-07 | 2013-04-11 | Radiorx, Inc. | Organonitro thioether compounds and medical uses thereof |
KR101494280B1 (ko) * | 2012-12-28 | 2015-02-23 | 한국화학연구원 | 콜치신 유도체를 유효성분으로 포함하는 암의 예방 또는 치료용 조성물 |
JO3705B1 (ar) | 2014-11-26 | 2021-01-31 | Bayer Pharma AG | إندازولات مستبدلة جديدة، عمليات لتحضيرها، مستحضرات دوائية تحتوي عليها واستخدامها في إنتاج أدوية |
CN104649943B (zh) * | 2015-01-28 | 2016-10-05 | 中国科学院上海高等研究院 | 秋水仙碱衍生物及其制备方法和应用 |
US10342778B1 (en) | 2015-10-20 | 2019-07-09 | Epicentrx, Inc. | Treatment of brain metastases using organonitro compound combination therapy |
US9987270B1 (en) | 2015-10-29 | 2018-06-05 | Epicentrix, Inc. | Treatment of gliomas using organonitro compound combination therapy |
AU2017207304B2 (en) | 2016-01-11 | 2022-05-26 | Epicentrx, Inc. | Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone |
US10435396B2 (en) | 2016-03-03 | 2019-10-08 | Bayer Pharma Aktiegesellschaft | 2-substituted indazoles, methods for producing same, pharmaceutical preparations that contain same, and use of same to produce drugs |
WO2017207385A1 (de) | 2016-05-31 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituierte 3-methylindazole, verfahren zu ihrer herstellung, pharmazeutische präparate, die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln |
ES2898771T3 (es) | 2016-06-01 | 2022-03-08 | Bayer Animal Health Gmbh | Indazoles sustituidos útiles para el tratamiento y la prevención de enfermedades alérgicas y/o inflamatorias en animales |
WO2018060174A1 (de) | 2016-09-29 | 2018-04-05 | Bayer Pharma Aktiengesellschaft | Substituierte benzimidazole, pharmazeutische präparate diese enthaltend, sowie deren verwendung zur herstellung von arzneimitteln |
BR112019007453A2 (pt) | 2016-10-14 | 2019-07-16 | Epicentrx Inc | organonitro de sulfoxialquila e compostos relacionados e composições farmacêuticas para uso em medicina |
CN109843862B (zh) * | 2016-10-26 | 2021-10-29 | 石原产业株式会社 | 3-甲基-2-噻吩羧酸的制造方法 |
SG11201914046WA (en) | 2017-07-07 | 2020-01-30 | Epicentrx Inc | Compositions for parenteral administration of therapeutic agents |
US11510901B2 (en) | 2018-01-08 | 2022-11-29 | Epicentrx, Inc. | Methods and compositions utilizing RRx-001 combination therapy for radioprotection |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4533675A (en) | 1984-04-17 | 1985-08-06 | The United States Of America As Represented By The Department Of Health And Human Services | Carbamates of colchicine for treatment of gout |
IT1276996B1 (it) * | 1995-06-27 | 1997-11-04 | Indena Spa | Derivati della colchicina, loro uso e formulazioni che li contengono |
IT1291550B1 (it) | 1997-04-11 | 1999-01-11 | Indena Spa | Derivati della colchicina e della tiocolchicina ad attivita' antinfiammatoria e miorilassante |
JP2004529204A (ja) * | 2001-05-28 | 2004-09-24 | ケムテック、リサーチ、インコーポレーション | 新規なアルカロイド誘導体及びこれを含有する医薬組成物 |
-
2004
- 2004-06-23 DE DE602004031621T patent/DE602004031621D1/de not_active Expired - Lifetime
- 2004-06-23 US US10/562,615 patent/US20070179143A1/en not_active Abandoned
- 2004-06-23 JP JP2006515341A patent/JP4430071B2/ja not_active Expired - Lifetime
- 2004-06-23 DK DK04773996.6T patent/DK1646608T3/da active
- 2004-06-23 CN CNB2004800212673A patent/CN100393698C/zh not_active Expired - Lifetime
- 2004-06-23 WO PCT/KR2004/001518 patent/WO2004113281A1/en active Application Filing
- 2004-06-23 KR KR1020040047277A patent/KR100667464B1/ko active IP Right Grant
- 2004-06-23 AU AU2004249639A patent/AU2004249639B2/en not_active Ceased
- 2004-06-23 ES ES04773996T patent/ES2358801T3/es not_active Expired - Lifetime
- 2004-06-23 RU RU2006101987/04A patent/RU2326864C2/ru not_active IP Right Cessation
- 2004-06-23 EP EP04773996A patent/EP1646608B1/en not_active Expired - Lifetime
- 2004-06-23 CA CA2531543A patent/CA2531543C/en not_active Expired - Fee Related
- 2004-06-23 AT AT04773996T patent/ATE500216T1/de active
-
2007
- 2007-02-27 HK HK07102213.0A patent/HK1095133A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2326864C2 (ru) | 2008-06-20 |
DE602004031621D1 (de) | 2011-04-14 |
ATE500216T1 (de) | 2011-03-15 |
JP2007520422A (ja) | 2007-07-26 |
CA2531543A1 (en) | 2004-12-29 |
AU2004249639B2 (en) | 2008-07-17 |
US20070179143A1 (en) | 2007-08-02 |
CN100393698C (zh) | 2008-06-11 |
AU2004249639A1 (en) | 2004-12-29 |
RU2006101987A (ru) | 2006-07-10 |
CN1826316A (zh) | 2006-08-30 |
DK1646608T3 (da) | 2011-06-14 |
ES2358801T3 (es) | 2011-05-13 |
EP1646608A4 (en) | 2006-11-22 |
CA2531543C (en) | 2010-10-12 |
KR100667464B1 (ko) | 2007-01-10 |
WO2004113281A1 (en) | 2004-12-29 |
EP1646608B1 (en) | 2011-03-02 |
JP4430071B2 (ja) | 2010-03-10 |
EP1646608A1 (en) | 2006-04-19 |
KR20050001383A (ko) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1095133A1 (en) | Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them | |
GEP20104994B (en) | Tetrahydroindolone and tetrahydroindazolone derivatives | |
TNSN04213A1 (en) | High drug load tablet | |
SG147485A1 (en) | Pharmaceutical compositions for prevention of overdose or abuse | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
IL185063A0 (en) | Pyrazole derivatives, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for treatment and prevention of cancers | |
WO2005044181A3 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
GEP20043250B (en) | Use of Indolyl-3-Glyoxylic Acid Derivatives as Anti-tumor Means and Pharmaceutical Compositions Containing the Same | |
SE0302192D0 (sv) | Novel compounds | |
TW200639156A (en) | New compounds | |
TW200630343A (en) | 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
YU87202A (sh) | Derivati arilmetilamina koji se koriste kao inhibitori triptaze | |
WO2006113495A3 (en) | Dicarboxylic acid ester derivatives of ginsenoside, pharmaceutical preparations containing the same, and preparation thereof | |
MY138923A (en) | Combination chemotherapy | |
WO2005065074A3 (en) | Protection of tissues and cells from cytotoxic effects of ionizing radiation by abl inhibitors | |
TW200719899A (en) | Tricyclic azole derivatives, their manufacture and use as pharmaceutical agents | |
WO2009045053A3 (en) | A cancer sensitizer comprising chlorogenic acid | |
ATE482922T1 (de) | Aloe-emodinderivate und deren verwendung in der behandlung von neoplasien | |
HK1167388A1 (en) | Anticancer compound and pharmaceutical composition containing the same | |
MX2010003594A (es) | Formas cristalinas de sal sodica de dmxaa. | |
TNSN06003A1 (en) | Saquinavir mesylate oral dosage form | |
IL163608A (en) | Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders | |
IL191670A0 (en) | Compounds for the inhibition of apoptosis | |
MY133230A (en) | Combination of no synthase inhibitor(s) and metabolic antioxidant(s) | |
DE60206940D1 (de) | Pektin und ascorbinsäure enthaltende zusammensetzungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20170623 |